GuiZhou SanLi Pharmaceutical Co.,Ltd
SSE:603439.SS
12.16 (CNY) • At close June 6, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||||||
| Current Assets: | ||||||||||||
| Cash & Cash Equivalents
| 474.845 | 571.372 | 570.884 | 544.218 | 450.051 | 239.615 | 131.43 | 180.462 | 177.277 | 18.682 | 16.69 | 28.939 |
| Short Term Investments
| 22.945 | 51.5 | 59.909 | 98 | 130 | 0 | 53.978 | 0 | 0 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 497.79 | 622.872 | 630.793 | 642.218 | 450.051 | 239.615 | 131.43 | 180.462 | 177.277 | 18.682 | 16.69 | 28.939 |
| Net Receivables
| 939.22 | 682.857 | 432.823 | 364.625 | 288.77 | 248.279 | 204.018 | 193.81 | 142.116 | 91.997 | 95.665 | 47.965 |
| Inventory
| 320.722 | 175.725 | 98.076 | 88.567 | 47.508 | 53.34 | 51.878 | 44.125 | 58.584 | 59.229 | 39.618 | 33.948 |
| Other Current Assets
| 40.253 | 12.017 | 10.366 | 55.962 | 183.888 | 10.877 | 7.696 | 201.163 | 4.922 | 96.731 | 42.313 | 64.851 |
| Total Current Assets
| 1,797.985 | 1,493.471 | 1,172.058 | 1,099.548 | 920.014 | 552.111 | 395.022 | 425.75 | 380.453 | 174.641 | 194.286 | 175.702 |
| Non-Current Assets: | ||||||||||||
| Property, Plant & Equipment, Net
| 573.546 | 615.125 | 237.404 | 157.907 | 154.357 | 111.151 | 115.412 | 122.085 | 122.728 | 117.116 | 43.945 | 22.564 |
| Goodwill
| 554.606 | 554.606 | 161.658 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 216.128 | 235.229 | 107.298 | 20.385 | 11.84 | 8.296 | 8.377 | 8.561 | 8.804 | 9.047 | 9.29 | 0.068 |
| Goodwill and Intangible Assets
| 770.734 | 789.835 | 268.956 | 20.385 | 11.84 | 8.296 | 8.377 | 8.561 | 8.804 | 9.047 | 9.29 | 0.068 |
| Long Term Investments
| -0.398 | 10.08 | 69.86 | 21.131 | 117.619 | 54.571 | 0 | 5.722 | 2.962 | -1.862 | -1.064 | -1.282 |
| Tax Assets
| 15.129 | 11.084 | 6.895 | 5.123 | 4.76 | 4.678 | 3.913 | 3.308 | 3.077 | 1.862 | 1.064 | 1.282 |
| Other Non-Current Assets
| 35.112 | 0.856 | 61.446 | 100.897 | 50.202 | 0 | 53.978 | 0 | 0 | 1.862 | 1.064 | 1.282 |
| Total Non-Current Assets
| 1,394.123 | 1,426.98 | 644.561 | 305.444 | 338.777 | 178.696 | 181.681 | 139.676 | 137.571 | 128.025 | 54.299 | 23.914 |
| Total Assets
| 3,192.108 | 2,920.451 | 1,816.619 | 1,404.991 | 1,258.791 | 730.806 | 576.703 | 565.426 | 518.024 | 302.666 | 248.585 | 199.616 |
| Liabilities & Equity: | ||||||||||||
| Current Liabilities: | ||||||||||||
| Account Payables
| 360.624 | 294.705 | 178.354 | 99.456 | 36.11 | 36.998 | 22.552 | 23.64 | 30.081 | 27.494 | 26.977 | 50.846 |
| Short Term Debt
| 351.522 | 311.805 | 205 | 200 | 200 | 0 | 0 | 0 | 0 | 0 | 60.6 | 31 |
| Tax Payables
| 72.638 | 12.772 | 37.203 | 21.013 | 17.718 | 19.541 | 17.296 | 30.155 | 16.752 | 12.801 | 7.59 | 4.857 |
| Deferred Revenue
| 0 | 0 | 78.964 | 60.209 | 27.034 | 1.982 | 0 | 3.7 | 6.841 | 4.478 | 51.338 | 48.086 |
| Other Current Liabilities
| 449.674 | 219.729 | 128.126 | 39.954 | 4.187 | 9.641 | 6.872 | 26.384 | 29.316 | 39.739 | 44.502 | 43.822 |
| Total Current Liabilities
| 1,234.457 | 839.01 | 548.683 | 360.423 | 263.91 | 66.18 | 46.721 | 80.179 | 76.149 | 80.034 | 139.669 | 130.524 |
| Non-Current Liabilities: | ||||||||||||
| Long Term Debt
| 209.512 | 298.153 | 0.17 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 42.971 | 35.971 | 12.503 | 12.504 | 13.004 | 13.542 | 11.966 | 11.891 | 11.286 | 6.105 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 25.499 | 28.878 | 6.945 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 85.043 | 9.085 | 10.098 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Non-Current Liabilities
| 363.024 | 372.087 | 29.716 | 12.504 | 13.004 | 13.542 | 11.966 | 11.891 | 11.286 | 6.105 | 0 | 0 |
| Total Liabilities
| 1,597.481 | 1,211.098 | 578.398 | 372.926 | 276.914 | 79.721 | 58.687 | 92.07 | 87.435 | 86.14 | 139.669 | 130.524 |
| Equity: | ||||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 409.802 | 409.862 | 410.862 | 410.862 | 407.322 | 366.582 | 366.582 | 366.582 | 128.176 | 111.445 | 50.15 | 48.6 |
| Retained Earnings
| 935.863 | 763.744 | 533.208 | 352.986 | 317.982 | 233.349 | 113.771 | 84.656 | 50.652 | 47.348 | 44.08 | 17.985 |
| Accumulated Other Comprehensive Income/Loss
| 0 | 0 | 75.258 | 47.895 | 59.883 | 50.563 | 0 | 22.117 | 251.761 | 57.733 | 0 | 0 |
| Other Total Stockholders Equity
| 181.675 | 296.705 | 294.974 | 267.61 | 256.589 | 0.604 | 37.664 | 0 | 251.761 | 57.733 | 9.28 | 2.506 |
| Total Shareholders Equity
| 1,527.34 | 1,470.311 | 1,239.044 | 1,031.458 | 981.893 | 651.099 | 518.017 | 473.355 | 430.589 | 216.526 | 108.916 | 69.092 |
| Total Equity
| 1,594.627 | 1,709.353 | 1,238.221 | 1,032.065 | 981.877 | 651.085 | 518.015 | 473.355 | 430.589 | 216.526 | 108.916 | 69.092 |
| Total Liabilities & Shareholders Equity
| 3,192.108 | 2,920.451 | 1,816.619 | 1,404.991 | 1,258.791 | 730.806 | 576.703 | 565.426 | 518.024 | 302.666 | 248.585 | 199.616 |